Annual Gross Margin
N/A
01 December 2023
Summary:
Plus Therapeutics annual gross profit margin is not available.PSTV Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
N/A
01 September 2024
Summary:
Plus Therapeutics quarterly gross profit margin is not available.PSTV Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Gross Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PSTV Gross Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Plus Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | 79.22%(-5.0%) |
| Mar 2018 | - | 83.43%(+6.1%) |
| Dec 2017 | 79.44%(-1.8%) | 78.66%(-12.4%) |
| Sept 2017 | - | 89.79%(+22.5%) |
| June 2017 | - | 73.27%(-1.7%) |
| Mar 2017 | - | 74.52%(-5.6%) |
| Dec 2016 | 80.93%(+11.4%) | 78.96%(+0.6%) |
| Sept 2016 | - | 78.51%(-4.5%) |
| June 2016 | - | 82.19%(-2.1%) |
| Mar 2016 | - | 83.96%(+9.7%) |
| Dec 2015 | 72.67%(+18.5%) | 76.57%(-4.0%) |
| Sept 2015 | - | 79.73%(+27.5%) |
| June 2015 | - | 62.55%(-16.1%) |
| Mar 2015 | - | 74.51%(+19.3%) |
| Dec 2014 | 61.31%(-14.8%) | 62.43%(-10.1%) |
| Sept 2014 | - | 69.45%(+70.8%) |
| June 2014 | - | 40.67%(-42.4%) |
| Mar 2014 | - | 70.64%(+4.7%) |
| Dec 2013 | 71.95%(-0.6%) | 67.49%(+2.8%) |
| Sept 2013 | - | 65.66%(-10.3%) |
| June 2013 | - | 73.18%(-8.4%) |
| Mar 2013 | - | 79.88%(-1.1%) |
| Dec 2012 | 72.42%(+17.5%) | 80.73%(+73.3%) |
| Sept 2012 | - | 46.58%(-39.0%) |
| June 2012 | - | 76.42%(+79.7%) |
| Mar 2012 | - | 42.52%(-36.3%) |
| Dec 2011 | 61.61%(-2.6%) | 66.74%(+19.3%) |
| Sept 2011 | - | 55.96%(+3.2%) |
| June 2011 | - | 54.21%(-19.8%) |
| Mar 2011 | - | 67.58%(+25.9%) |
| Dec 2010 | 63.23%(-17.8%) | 53.67%(+28.0%) |
| Sept 2010 | - | 41.92%(-27.6%) |
| June 2010 | - | 57.91%(-26.6%) |
| Mar 2010 | - | 78.91%(+6.3%) |
| Dec 2009 | 76.96% | 74.21%(+70.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2009 | - | 43.58%(-52.1%) |
| June 2009 | - | 90.91%(+109.5%) |
| Mar 2009 | - | 43.39%(-44.5%) |
| Dec 2008 | 72.95%(+56.1%) | 78.12%(+8.4%) |
| Sept 2008 | - | 72.07%(+38.8%) |
| June 2008 | - | 51.92%(-14.6%) |
| Mar 2008 | - | 60.78%(-1.2%) |
| Dec 2007 | 46.72%(-41.2%) | - |
| June 2007 | - | 61.52%(+213.2%) |
| Mar 2007 | - | 19.64%(-79.5%) |
| Dec 2006 | 79.39%(+67.2%) | 95.72%(-150.9%) |
| Sept 2006 | - | -187.97%(+1569.4%) |
| June 2006 | - | -11.26%(-217.8%) |
| Mar 2006 | - | 9.56%(-70.1%) |
| Dec 2005 | 47.48%(-5.7%) | 32.02%(-22.5%) |
| Sept 2005 | - | 41.34%(-20.7%) |
| June 2005 | - | 52.11%(-9.5%) |
| Mar 2005 | - | 57.55%(+363.7%) |
| Dec 2004 | 50.37%(-27.9%) | 12.41%(-62.7%) |
| Sept 2004 | - | 33.26%(-58.2%) |
| June 2004 | - | 79.61%(+51.9%) |
| Mar 2004 | - | 52.42%(-26.2%) |
| Dec 2003 | 69.88%(+6.8%) | 71.01%(+4.4%) |
| Sept 2003 | - | 68.01%(-6.7%) |
| June 2003 | - | 72.89%(+9.0%) |
| Mar 2003 | - | 66.87%(-50.3%) |
| Dec 2002 | 65.43%(+13.8%) | 134.59%(+364.9%) |
| Sept 2002 | - | 28.95%(-54.6%) |
| June 2002 | - | 63.76%(+26.4%) |
| Mar 2002 | - | 50.45%(-60.6%) |
| Dec 2001 | 57.49%(-6.8%) | 127.91%(+139.7%) |
| Sept 2001 | - | 53.36%(-157.3%) |
| June 2001 | - | -93.10% |
| Dec 2000 | 61.70%(-9.1%) | - |
| Dec 1999 | 67.88% | - |
FAQ
- What is the all time high annual gross margin for Plus Therapeutics?
- What is the all time high quarterly gross margin for Plus Therapeutics?
What is the all time high annual gross margin for Plus Therapeutics?
Plus Therapeutics all-time high annual gross profit margin is 80.93%
What is the all time high quarterly gross margin for Plus Therapeutics?
Plus Therapeutics all-time high quarterly gross profit margin is 134.59%